These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 28273381)

  • 21. Quinupristin-dalfopristin and linezolid: evidence and opinion.
    Eliopoulos GM
    Clin Infect Dis; 2003 Feb; 36(4):473-81. PubMed ID: 12567306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intra-hospital dissemination of quinupristin/dalfopristin- and vancomycin-resistant Enterococcus faecium in a paediatric ward of a German hospital.
    Werner G; Klare I; Spencker FB; Witte W
    J Antimicrob Chemother; 2003 Jul; 52(1):113-5. PubMed ID: 12805253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of vancomycin-resistant enterococcus with quinupristin/dalfopristin and high-dose ampicillin.
    Bethea JA; Walko CM; Targos PA
    Ann Pharmacother; 2004 Jun; 38(6):989-91. PubMed ID: 15100393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergy testing of vancomycin-resistant Enterococcus faecium against quinupristin-dalfopristin in combination with other antimicrobial agents.
    Matsumura SO; Louie L; Louie M; Simor AE
    Antimicrob Agents Chemother; 1999 Nov; 43(11):2776-9. PubMed ID: 10543762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of Oritavancin Dosing Strategies against Vancomycin-Resistant Enterococcus faecium Isolates with or without Reduced Susceptibility to Daptomycin in an
    Belley A; Arhin FF; Moeck G
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29109163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emergence of resistance of vancomycin-resistant Enterococcus faecium in a thermal injury patient treated with quinupristin-dalfopristin and cultured epithelial autografts for wound closure.
    Rose CM; Reilly KJ; Haith LR; Patton ML; Guilday RJ; Cawley MJ; Ackerman BH
    Burns; 2002 Nov; 28(7):696-8. PubMed ID: 12417169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Varying linezolid susceptibility of vancomycin-resistant Enterococcus faecium isolates during therapy: a case report.
    Swoboda S; Fritz S; Martignoni ME; Feldhues RA; Hoppe-Tichy T; Buchler MW; Geiss HK
    J Antimicrob Chemother; 2005 Oct; 56(4):787-9. PubMed ID: 16143710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vancomycin-resistant Enterococcus faecium meningitis in adults: case series and review of the literature.
    Knoll BM; Hellmann M; Kotton CN
    Scand J Infect Dis; 2013 Feb; 45(2):131-9. PubMed ID: 22992165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular characterization of vancomycin-resistant Enterococcus spp. clinical isolates recovered from hospitalized patients among several medical institutions in China.
    Sun H; Wang H; Xu Y; Jones RN; Costello AJ; Liu Y; Li G; Chen M; Mendes RE
    Diagn Microbiol Infect Dis; 2012 Dec; 74(4):399-403. PubMed ID: 23099304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of vancomycin-resistant Enterococcus faecium infections.
    Lai KK
    Arch Intern Med; 1996 Dec 9-23; 156(22):2579-84. PubMed ID: 8951301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective, randomized study comparing quinupristin-dalfopristin with linezolid in the treatment of vancomycin-resistant Enterococcus faecium infections.
    Raad I; Hachem R; Hanna H; Afif C; Escalante C; Kantarjian H; Rolston K
    J Antimicrob Chemother; 2004 Apr; 53(4):646-9. PubMed ID: 14998986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emerging issues in the diagnosis and management of infections caused by multi-drug-resistant, gram-positive cocci.
    Napolitano LM
    Surg Infect (Larchmt); 2005; 6 Suppl 2():S-5-22. PubMed ID: 23577494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Vancomycin-resistant enterococci (VRE). Recent results and trends in development of antibiotic resistance].
    Klare I; Witte W; Wendt C; Werner G
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 Nov; 55(11-12):1387-400. PubMed ID: 23114437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimizing therapy for vancomycin-resistant enterococci (VRE).
    Linden PK
    Semin Respir Crit Care Med; 2007 Dec; 28(6):632-45. PubMed ID: 18095227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bactericidal activity of daptomycin, vancomycin, teicoplanin and linezolid against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium using human peak free serum drug concentrations.
    Brauers J; Kresken M; Menke A; Orland A; Weiher H; Morrissey I
    Int J Antimicrob Agents; 2007 Mar; 29(3):322-5. PubMed ID: 17204403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Enterococcus faecium cholangitis resistant to vancomycin and quinupristin-dalfopristin].
    Maseda E; Uña R; Ureta P; Royo C
    Med Clin (Barc); 2002 Sep; 119(7):276-7. PubMed ID: 12236991
    [No Abstract]   [Full Text] [Related]  

  • 37. Evaluation of the novel combination of daptomycin plus ceftriaxone against vancomycin-resistant enterococci in an in vitro pharmacokinetic/pharmacodynamic simulated endocardial vegetation model.
    Hall Snyder A; Werth BJ; Barber KE; Sakoulas G; Rybak MJ
    J Antimicrob Chemother; 2014 Aug; 69(8):2148-54. PubMed ID: 24777900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro activities of Daptomycin, Linezolid, and Quinupristin-Dalfopristin against a challenge panel of Staphylococci and Enterococci, including vancomycin-intermediate staphylococcus aureus and vancomycin-resistant Enterococcus faecium.
    Jevitt LA; Smith AJ; Williams PP; Raney PM; McGowan JE; Tenover FC
    Microb Drug Resist; 2003; 9(4):389-93. PubMed ID: 15000746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. First documented isolation of vancomycin-resistant Enterococcus faecium in Sweden.
    Melhus A; Tjernberg I
    Scand J Infect Dis; 1996; 28(2):191-3. PubMed ID: 8792490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative Pharmacodynamics of Single-Dose Oritavancin and Daily High-Dose Daptomycin Regimens against Vancomycin-Resistant Enterococcus faecium Isolates in an
    Belley A; Lalonde-Séguin D; Arhin FF; Moeck G
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.